XML 21 R4.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Revenue        
Total revenue $ 165,169 $ 130,050 $ 330,274 $ 225,806
Operating expenses        
Cost of services 136,079 101,363 280,283 184,795
General and administrative expenses 11,556 11,818 23,390 22,081
Depreciation and amortization 4,628 4,455 9,330 8,872
Provision for doubtful accounts 0 (2,314) 0 (1,363)
Total expenses 152,263 115,322 313,003 214,385
Income from operations 12,906 14,728 17,271 11,421
Other income (expense)        
Income (loss) from equity method investments 834 (42) 2,888 (892)
Gain on sale of equity method investment 99,647 0 99,647 0
Interest expense (2,673) (311) (5,541) (522)
Interest income 863 474 1,792 797
Other income 1,282 24 1,384 211
Total other income (expense), net 99,953 145 100,170 (406)
Income before provision for income taxes 112,859 14,873 117,441 11,015
Provision for income taxes 31,858 4,209 33,453 2,801
 Net income 81,001 10,664 83,988 8,214
Net income attributable to noncontrolling interests 73,957 7,119 72,892 4,529
Net income attributable to Apollo Medical Holdings, Inc. $ 7,044 $ 3,545 $ 11,096 $ 3,685
Earnings per share – basic (in dollars per share) $ 0.20 $ 0.10 $ 0.31 $ 0.11
Earnings per share – diluted (in dollars per share) $ 0.19 $ 0.09 $ 0.30 $ 0.10
Capitation, net        
Revenue        
Total revenue $ 140,949 $ 103,224 $ 281,370 $ 174,740
Risk pool settlements and incentives        
Revenue        
Total revenue 12,003 11,191 23,239 21,285
Management fee income        
Revenue        
Total revenue 8,690 10,353 17,505 19,349
Fee-for-service, net        
Revenue        
Total revenue 2,270 3,878 5,697 7,959
Other income        
Revenue        
Total revenue $ 1,257 $ 1,404 $ 2,463 $ 2,473